Ultragenyx Announces Approval of Dojolvi® (triheptanoin

Ultragenyx Announces Approval of Dojolvi® (triheptanoin) in Brazil for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children | Comunicados | Edición USA

Ultragenyx Announces Approval of Dojolvi® (triheptanoin) in Brazil for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children | Comunicados | Edición USA

efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Brazil , Sao Paulo , Sãpaulo , Portugal , Guarulhos , Canada , Brazilian , Portuguese , Joshua Higa , Eduardo Thompson , Rua Josefina , Vitor Brandao , Carolyn Wang , Health System , Ultragenyx Pharmaceutical Inc , Exchange Commission On , Regulatory Affairs , Ministry Of Health , Drug Administration , Nasdaq , Exchange Commission , Administration Of Dojolvi , Brazil National Health Surveillance Agency , Health Canada , National Newborn Screening Program , Ultragenyx Announces Approval , Long Chain Fatty Acid Oxidation Disorders , National Health Surveillance Agency , Senior Vice President , Regional Head , Latin America , Unified Health System , Ultragenyx Pharmaceutical , Prescribing Information , Private Securities Litigation Reform Act , Quarterly Report , Regulatory Affairs Director ,